Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Differential quantification of cloned CVI988 vaccine strain and virulent RB-1B strain of Marek's disease viruses in chicken tissues, using real-time PCR.

Baigent SJ, Smith LP, Petherbridge LJ, Nair VK.

Res Vet Sci. 2011 Aug;91(1):167-74. doi: 10.1016/j.rvsc.2010.08.002. Epub 2010 Aug 31.

PMID:
20810138
2.

Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.

Baigent SJ, Nair VK, Le Galludec H.

J Virol Methods. 2016 Jul;233:23-36. doi: 10.1016/j.jviromet.2016.03.002. Epub 2016 Mar 10.

4.

Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.

Lee LF, Kreager KS, Arango J, Paraguassu A, Beckman B, Zhang H, Fadly A, Lupiani B, Reddy SM.

Vaccine. 2010 Feb 3;28(5):1294-9. doi: 10.1016/j.vaccine.2009.11.022. Epub 2009 Nov 24.

PMID:
19941987
5.

Differential amplification of Marek's disease CVI988 vaccine and of wild-type isolates from organs of commercial chickens using single or duplexed probes in real-time PCR.

Davidson I, Natour-Altoury A, Raibstein I, Dahan Y.

Avian Pathol. 2017 Dec;46(6):610-614. doi: 10.1080/03079457.2017.1332402. Epub 2017 Aug 1.

PMID:
28532188
7.

Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.

Baigent SJ, Smith LP, Nair VK, Currie RJ.

Vet Immunol Immunopathol. 2006 Jul 15;112(1-2):78-86. Epub 2006 May 8. Review.

PMID:
16682084
8.

A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.

Shaikh SA, Katneni UK, Dong H, Gaddamanugu S, Tavlarides-Hontz P, Jarosinski KW, Osterrieder N, Parcells MS.

Avian Dis. 2013 Jun;57(2 Suppl):509-18.

PMID:
23901769
9.
10.

Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis.

Renz KG, Cheetham BF, Walkden-Brown SW.

J Virol Methods. 2013 Jan;187(1):144-52. doi: 10.1016/j.jviromet.2012.09.018. Epub 2012 Oct 3.

PMID:
23041147
11.

Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens.

Cui HY, Wang YF, Shi XM, An TQ, Tong GZ, Lan DS, He L, Liu CJ, Wang M.

J Virol Methods. 2009 Mar;156(1-2):66-72. doi: 10.1016/j.jviromet.2008.10.021. Epub 2008 Dec 16.

PMID:
19026690
12.

Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.

Gimeno IM, Dunn JR, Cortes AL, El-Gohary Ael-G, Silva RF.

Avian Dis. 2014 Jun;58(2):232-43.

PMID:
25055627
13.

Molecular identification of the Marek's disease virus vaccine strain CVI988 in vaccinated chickens.

Davidson I, Borenshtain R, Weisman Y.

J Vet Med B Infect Dis Vet Public Health. 2002 Mar;49(2):83-7.

PMID:
12002424
14.

Replication kinetics and shedding of very virulent Marek's disease virus and vaccinal Rispens/CVI988 virus during single and mixed infections varying in order and interval between infections.

Islam T, Walkden-Brown SW, Renz KG, Islam AF, Ralapanawe S.

Vet Microbiol. 2014 Oct 10;173(3-4):208-23. doi: 10.1016/j.vetmic.2014.07.027. Epub 2014 Aug 15.

PMID:
25213229
15.
16.

Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.

Ralapanawe S, Walkden-Brown SW, Renz KG, Islam AF.

Avian Pathol. 2016;45(1):26-37. doi: 10.1080/03079457.2015.1110850.

PMID:
26503904
17.

[Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].

Duan L, Su S, Wang Y, Li S, Sun P, Chen W, Cui Z.

Wei Sheng Wu Xue Bao. 2014 Nov 4;54(11):1353-61. Chinese.

PMID:
25752142
18.
19.
20.

Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.

Chang S, Xie Q, Dunn JR, Ernst CW, Song J, Zhang H.

Vaccine. 2014 Apr 1;32(16):1820-7. doi: 10.1016/j.vaccine.2014.01.092. Epub 2014 Feb 13.

PMID:
24530405

Supplemental Content

Support Center